Market Overview:
The global noscapine base market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of cancer and other chronic diseases, rising demand for generic drugs, and growing investments in R&D by pharmaceutical companies. Based on type, the global noscapine base market is segmented into oral administration, buccal administration, and sublingual administration. Oral administration is further segmented into tablets/capsules and syrups/suspensions. Buccal administration is further divided into lozenges and gels/creams. Sublingual administration is subdivided into tablets/lozenges and sprays/drops. By application, the global noscapine base market is classified into healthcare sector and pharmaceutical industry sector. Healthcare sector includes hospitals & clinics (inpatient & outpatient), diagnostic centers & laboratories (clinical pathology labs), research institutes (pharmaceutical research institutes) etc., whereas pharmaceutical industry sector comprises of drug manufacturers (generic drug manufacturers as well as innovator companies), contract manufacturing organizations (CMOs) etc. Geographically, the global noscapine base market has been segmented into North America, Latin America Europe Asia Pacific Middle East & Africa).
Product Definition:
A base that is used to make the drug noscapine. Noscapine is a cough suppressant that is used to treat mild to moderate cases of coughing.
Oral Administration:
Oral administration is the process of delivering a drug substance by mouth. The substance can be in solid or liquid form and it depends on the type of drug. Most commonly, oral administration involves the use of tablets or capsules that are designed for human consumption; however, it also includes other methods such as chewing gums and sprays.
Buccal Administration:
Buccal (or oral) administration is the most common route of drug delivery. It includes administering active pharmaceutical ingredients to patients in the form of mouthwashes, tablets, solutions and sprays. The most commonly used route for drugs with fast-acting therapeutic effects is buccal administration because it allows rapid absorption into systemic circulation after application on the oral mucosa.
The advantages of this mode of drug delivery include ease in self-administration by a patient.
Application Insights:
The healthcare segment dominated the global noscapine base market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to increasing awareness about essential oils, coupled with rising health problems such as anxiety disorders, cardiovascular diseases, respiratory problems and gastrointestinal conditions. In addition, growing demand for natural products owing to their medicinal benefits is also expected to drive the segment growth over the forecast period.
The pharmaceutical industry accounted for a share of 22% in terms of revenue in 2017 due to high product usage across various indications such as anxiety disorder treatment and cough suppression. The oil also finds applications in aromatherapy along with being used traditionally for its antifungal, antibacterial and antiseptic properties among others which are likely drive its demand further during this study period.
Regional Analysis:
North America dominated the global noscapine base market in 2017. The region is expected to witness a considerable growth rate of 4.8% over the forecast period, owing to an increase in product consumption and development of new formulations for easy administration. In addition, increasing awareness about pain management and presence of effective treatment methods are some other factors driving the market growth in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions due to rising disposable income coupled with growing health awareness among people leading to increased demand for medicines across various applications such as oral tablets & capsules, buccal tablets & capsules, sublingual drops/tablets etc.
Growth Factors:
- Increasing prevalence of cancer and other chronic diseases: The global noscapine base market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing prevalence of cancer and other chronic diseases. Noscapine is used as an antitussive agent for the treatment of coughs and is also effective in reducing pain in patients with cancer.
- Rising demand for generic drugs: The growth of the noscapine base market can also be attributed to the rising demand for generic drugs, as they are cheaper than branded drugs and offer similar efficacy. Generic drug manufacturers are focusing on developing new products that can compete with branded counterparts in terms of quality, safety, and efficacy.
- Technological advancements in drug delivery systems: Technological advancements have led to the development of novel drug delivery systems that improve bioavailability and patient compliance rates. This is likely to boost the growth prospects of the noscapine base market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Noscapine Base Market Research Report
By Type
Oral Administration, Buccal Administration, Sublingual
By Application
Healthcare, Pharmaceutical Industry
By Companies
3B Scientific Corporation, Tianjin heowns Biochemical Technology Co., Ltd, Spectrum China, Guangzhou Isun Pharmaceutical Co., Ltd, Franco-Indian Pharmaceuticals Pvt. Ltd, Inga Laboratories Pvt. Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Noscapine Base Market Report Segments:
The global Noscapine Base market is segmented on the basis of:
Types
Oral Administration, Buccal Administration, Sublingual
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Healthcare, Pharmaceutical Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3B Scientific Corporation
- Tianjin heowns Biochemical Technology Co., Ltd
- Spectrum China
- Guangzhou Isun Pharmaceutical Co., Ltd
- Franco-Indian Pharmaceuticals Pvt. Ltd
- Inga Laboratories Pvt. Ltd
Highlights of The Noscapine Base Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Administration
- Buccal Administration
- Sublingual
- By Application:
- Healthcare
- Pharmaceutical Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Noscapine Base Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Noscapine Base is a white to off-white crystalline powder with a bitter taste. It is used as an antipsychotic drug.
Some of the major companies in the noscapine base market are 3B Scientific Corporation, Tianjin heowns Biochemical Technology Co., Ltd, Spectrum China, Guangzhou Isun Pharmaceutical Co., Ltd, Franco-Indian Pharmaceuticals Pvt. Ltd, Inga Laboratories Pvt. Ltd.
The noscapine base market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Noscapine Base Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Noscapine Base Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Noscapine Base Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Noscapine Base Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Noscapine Base Market Size & Forecast, 2018-2028
4.5.1 Noscapine Base Market Size and Y-o-Y Growth
4.5.2 Noscapine Base Market Absolute $ Opportunity
Chapter 5 Global Noscapine Base Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Noscapine Base Market Size Forecast by Type
5.2.1 Oral Administration
5.2.2 Buccal Administration
5.2.3 Sublingual
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Noscapine Base Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Noscapine Base Market Size Forecast by Applications
6.2.1 Healthcare
6.2.2 Pharmaceutical Industry
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Noscapine Base Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Noscapine Base Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Noscapine Base Analysis and Forecast
9.1 Introduction
9.2 North America Noscapine Base Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Noscapine Base Market Size Forecast by Type
9.6.1 Oral Administration
9.6.2 Buccal Administration
9.6.3 Sublingual
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Noscapine Base Market Size Forecast by Applications
9.10.1 Healthcare
9.10.2 Pharmaceutical Industry
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Noscapine Base Analysis and Forecast
10.1 Introduction
10.2 Europe Noscapine Base Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Noscapine Base Market Size Forecast by Type
10.6.1 Oral Administration
10.6.2 Buccal Administration
10.6.3 Sublingual
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Noscapine Base Market Size Forecast by Applications
10.10.1 Healthcare
10.10.2 Pharmaceutical Industry
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Noscapine Base Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Noscapine Base Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Noscapine Base Market Size Forecast by Type
11.6.1 Oral Administration
11.6.2 Buccal Administration
11.6.3 Sublingual
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Noscapine Base Market Size Forecast by Applications
11.10.1 Healthcare
11.10.2 Pharmaceutical Industry
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Noscapine Base Analysis and Forecast
12.1 Introduction
12.2 Latin America Noscapine Base Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Noscapine Base Market Size Forecast by Type
12.6.1 Oral Administration
12.6.2 Buccal Administration
12.6.3 Sublingual
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Noscapine Base Market Size Forecast by Applications
12.10.1 Healthcare
12.10.2 Pharmaceutical Industry
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Noscapine Base Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Noscapine Base Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Noscapine Base Market Size Forecast by Type
13.6.1 Oral Administration
13.6.2 Buccal Administration
13.6.3 Sublingual
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Noscapine Base Market Size Forecast by Applications
13.10.1 Healthcare
13.10.2 Pharmaceutical Industry
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Noscapine Base Market: Competitive Dashboard
14.2 Global Noscapine Base Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3B Scientific Corporation
14.3.2 Tianjin heowns Biochemical Technology Co., Ltd
14.3.3 Spectrum China
14.3.4 Guangzhou Isun Pharmaceutical Co., Ltd
14.3.5 Franco-Indian Pharmaceuticals Pvt. Ltd
14.3.6 Inga Laboratories Pvt. Ltd
